
Skye Bioscience, Inc. Common Stock Share Price
NASDAQ: SKYEHealthcare
Live Skye Bioscience, Inc. Common Stock Share Price Chart
O H L
Skye Bioscience, Inc. Common Stock Performance Overview
Days Range
▼
$1.51Low
$1.71High
Markets Today
| Previous Close | $1.57 |
|---|---|
| Open | $1.69 |
| Volume | 94,773 |
| Day's Range | $1.51 - $1.71 |
| 52W Range | $1.64 - $39.92 |
| Market Cap | $7.53 M |
Historical Performance
| 1M Returns | -45.33 |
|---|---|
| 3M Returns | -72.25 |
| 6M Returns | -70.85 |
| 1Y Returns | -95.02 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Skye Bioscience, Inc. Common Stock Fundamentals
| Market Cap | $7.53 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -1.27 |
| EPS TTM | $-10.18 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-57.44 M |
| Profit Margin | N/A |
| Market Cap | $7.53 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -1.27 |
| EPS TTM | $-10.18 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-57.44 M |
| Profit Margin | N/A |
Skye Bioscience, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$11.76 M | -$18.24 M | -$13.26 M | -$14.90 M | -$12.67 M | -$11.06 M |
| EBITDA | -$11.58 M | -$18.06 M | -$13.09 M | -$14.72 M | -$12.50 M | -$10.90 M |
| Interest Expense | -$1.45 K | $0 | $0 | $0 | -$2.20 K | -$3.30 K |
| Depreciation | $177.38 K | $187.07 K | $178.90 K | $180.01 K | $172.89 K | $157.60 K |
| Income Before Tax | -$11.10 M | -$17.62 M | -$12.75 M | -$14.44 M | -$12.51 M | -$10.78 M |
| Income Tax Expense | $2.00 K | $3.40 K | $0 | $0 | $0 | $3.40 K |
| Net Income + | -$11.10 M | -$17.62 M | -$12.75 M | -$14.44 M | -$12.51 M | -$10.79 M |
| Net Profit Margin | - | - | - | - | - | - |
Skye Bioscience, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $30.98 K | $30.99 K | $30.99 K | $33.38 K | $35.13 K | $35.14 K |
| Reserve & Surplus | -$142.05 M | -$159.68 M | -$172.43 M | -$186.87 M | -$199.38 M | -$210.17 M |
| Non-Current Liabilities | $223.47 K | $172.49 K | $120.21 K | $84.00 K | $0 | $0 |
| Current Liabilities | $5.32 M | $8.31 M | $8.37 M | $8.21 M | $10.40 M | $11.53 M |
| Total Liabilities | $5.54 M | $8.48 M | $8.49 M | $8.29 M | $10.40 M | $11.53 M |
| Fixed Assets | $1.30 M | $1.17 M | $1.03 M | $898.93 K | $756.08 K | $32.94 K |
| Current Assets | $63.03 M | $50.58 M | $39.92 M | $27.09 M | $18.57 M | $10.96 M |
| Total Assets | $64.79 M | $52.16 M | $41.32 M | $28.31 M | $19.42 M | $11.03 M |
Skye Bioscience, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$11.10 M | -$17.62 M | -$12.75 M | -$14.44 M | -$12.51 M | -$10.79 M |
| Operating Cash Flow | -$9.19 M | -$10.75 M | -$13.36 M | -$9.77 M | -$8.56 M | -$7.12 M |
| Investing Cash Flow | -$12.81 M | -$11.86 M | $7.97 M | -$2.80 M | $10.90 M | $7.14 M |
| Financing Cash Flow | $0 | $18.16 K | $0 | $11.41 K | -$71.53 K | -$101.01 K |
| Change in Cash | -$21.99 M | -$22.58 M | -$5.40 M | -$12.56 M | $2.27 M | -$80.66 K |
Skye Bioscience, Inc. Common Stock Return Calculator
The Skye Bioscience, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Skye Bioscience, Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
Popular Stocks
FAQs
What is the share price of Skye Bioscience, Inc. Common Stock today?
Skye Bioscience, Inc. Common Stock (SKYE) share price as of September 18, 2026 is $1.64. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Skye Bioscience, Inc. Common Stock?
Yes, Indian Investors can invest in the Skye Bioscience, Inc. Common Stock (SKYE) Share by opening an international trading account with Angel One.
How can I purchase Skye Bioscience, Inc. Common Stock shares in India?
Purchasing Skye Bioscience, Inc. Common Stock (SKYE) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Skye Bioscience, Inc. Common Stock (SKYE) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Skye Bioscience, Inc. Common Stock?
Yes, you can purchase fractional shares of Skye Bioscience, Inc. Common Stock (SKYE) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Skye Bioscience, Inc. Common Stock?
The market capitalization of Skye Bioscience, Inc. Common Stock on September 18, 2026, is $7.53 M.
In which sector Skye Bioscience, Inc. Common Stock belongs?
Skye Bioscience, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Skye Bioscience, Inc. Common Stock stocks?
In order to invest in Skye Bioscience, Inc. Common Stock (SKYE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
